简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Video
Research
HOME
·
ClinicalTrialApproval
SIMCERE PHARMA(02096.HK): PD-1/VEGF Bispecific Antibody SIM0689 Approved for Clinical Trials by NMPA
Tags：
SIMCERE PHARMA
02096.HK
ClinicalTrialApproval
2026-06-12
Mabwell-B (02493.HK): 6MW5311 Injection Receives FDA Clinical Trial Approval as World’s First LILRB4/CD3-Targeted TCE Innovative Drug
Tags：
MABWELL-B
02493.HK
ClinicalTrialApproval
2026-06-12
SIMCERE PHARMA (02096.HK): SIM0613 (LRRC15 ADC) Receives NMPA Clinical Trial Approval
Tags：
SIMCERE PHARMA
02096.HK
ClinicalTrialApproval
2026-05-06
CSPC PHARMA(01093.HK): Antibody-Drug Conjugate SYS6051 Approved for Clinical Trials for Advanced Solid Tumors
Tags：
CSPC PHARMA
01093.HK
ClinicalTrialApproval
2026-04-15
Featured News
Finance
FIBOCOM (00638.HK): Closes Sale of Entire Stake in Shanghai Guangyi to Luxshare Precision; De-consolidated from 4 September
Finance
DEEP SOURCE (00990.HK): Malaysia AIDC Project Approved by MITI, Entering Accelerated Deployment Phase
Finance
POLY XVERSE IT (00209.HK): Chairman and Executive Director Zhao Kai Resigns, Effective 7 September 2026
Finance
BIOHEART-B (02185.HK): Appoints Former Medtronic and ReCor Medical Executive Giorgio Gobbi as VP of Global Therapy Development at AngioCare
Finance
UISEE TECH (01511.HK): Shares Added to Stock Connect Eligible Securities List, Effective 7 September 2026
Finance
MAJESTIC DRAGON (00918.HK): Appoints Zhang Chen as Chief Marketing Officer, Effective 7 December 2026
Research
HK Stock Connect Daily Report: HSI falls 0.93% as Stock Connect list adjustment takes effect, 54 stocks added and 15 removed - 20260907
Research
Weekly Hong Kong ETF Scale Change Statistics (by Management Company) (First Week of September 2026)
Research
Weekly Hong Kong ETF Scale Change Statistics (First Week of September 2026)
Research
HK shares ETFs Daily Report : Korea ETFs surge over 5%, Asian semiconductors mount a broad comeback while gold miners and biotech slump - 20260907
Scan QR Code
Download App
